Golimumab's Efficacy in Patients with Very Active Disease in Methotrexate-naive Rheumatoid Arthritis

被引：0

作者：

Emery, Paul ^{[1
,2
]}

Fleischmann, R. M. ^{[3
,4
]}

Hsia, Elizabeth C. ^{[5
]}

Xu, Stephen

Xu, Weichun ^{[6
]}

Baker, Daniel G. ^{[5
]}

机构：

[1] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England

[2] NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England

[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

[4] Metroplex Clin Res Ctr, Dallas, TX USA

[5] Centocor R&D, Malvern, PA USA

[6] Centocor R&D, Malvern, PA USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1210

引用

页码：S470 / S471

页数：2

共 50 条

[31] Comparative efficacy of methotrexate versus apremilast for methotrexate-naive psoriasis patients: An indirect comparison
Armstrong, April W.
Betts, Keith
Sundaram, Murali
Thomason, Darren
Signorovitch, James
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB229 - AB229
[32] PREDICTORS OF RADIOGRAPHIC PROGRESSION IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS BASED ON ONE-YEAR RADIOGRAPHIC DATA FROM THE GO-BEFORE GOLIMUMAB CLINICAL TRIAL
Emery, Paul
Fleischmann, Roy
Han, Chenglong
van der Heijde, Desiree
Conaghan, Philip
Xu, Weichun
Hsia, Elizabeth
RHEUMATOLOGY, 2012, 51 : 68 - 69
[33] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM SELECT-EARLY
Van Vollenhoven, R.
Takeuchi, T.
Rischmueller, M.
Blanco, R.
Xavier, R.
Howard, M.
Friedman, A.
Song, Y.
Strand, V.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 330 - 331
[34] Identification of Distinct Disease Activity Trajectories in Methotrexate-Naive Patients With Rheumatoid Arthritis Receiving Tofacitinib Over Twenty-Four Months
Bykerk, Vivian P.
Lee, Eun Bong
Vollenhoven, Ronald
Gruben, David C.
Fallon, Lara
Woolcott, John C.
Keystone, Edward
ARTHRITIS CARE & RESEARCH, 2022, 74 (01) : 131 - 141
[35] Longterm Remission with Golimumab in Active Rheumatoid Arthritis Patients Despite Methotrexate Through 2 Years
Keystone, Edward
Genovese, Mark
Klareskog, Lars
Xu, Stephen
Han, Chenglong
Hsia, Elizabeth
JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 968 - 968
[36] Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study
Baranauskaite, Asta
Raffayova, Helena
Kungurov, N. V.
Kubanova, Anna
Venalis, Algirdas
Helmle, Laszlo
Srinivasan, Shankar
Nasonov, Evgeny
Vastesaeger, Nathan
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (04) : 541 - 548
[37] Evaluation of golimumab for the treatment of patients with active rheumatoid arthritis
Tanaka, Yoshiya
Senoo, Asako
Fujii, Hideji
Baker, Daniel
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (03) : 319 - 326
[38] Abatacept Plus Methotrexate Provides Incremental Clinical Benefits Versus Methotrexate Alone in Methotrexate-naive Patients with Early Rheumatoid Arthritis Who Achieve Radiographic Nonprogression
Wells, Alvin F.
Westhovens, Rene
Reed, Diane Moniz
Fanti, Luciana
Becker, Jean-Claude
Covucci, Allison
Keystone, Edward C.
JOURNAL OF RHEUMATOLOGY, 2011, 38 (11) : 2362 - 2368
[39] Lack of Early Change in Disease Activity Score Predicts the Likelihood of Achieving Low Disease Activity at Month 6: Tofacitinib Monotherapy Versus Methotrexate in Methotrexate-Naive Patients with Rheumatoid Arthritis
Keystone, Edward
van Vollenhoven, Ronald F.
Wilkinson, Bethanie
Fallon, Lara
Hwang, Lie-Ju
Chapman, Douglass
DeMasi, Ryan
Lee, Eun Bong
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[40] Comparative efficacy and incremental cost per responder of methotrexate versus apremilast for methotrexate-naive patients with psoriasis
Armstrong, April W.
Betts, Keith A.
Sundaram, Murali
Thomason, Darren
Signorovitch, James E.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (04) : 740 - 746

← 1 2 3 4 5 →